ID

13471

Descripción

Randomized Phase III Study of Intensive Chemotherapy with or without Dasatinib (Sprycel(TM)) in Adult Patients with Newly Diagnosed Core-Binding Factor Acute Myeloid Leukemia (CBF-AML)

Palabras clave

  1. 8/3/15 8/3/15 -
  2. 9/12/15 9/12/15 -
  3. 11/2/16 11/2/16 -
Subido en

11 de febrero de 2016

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY-NC 3.0

Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Comentarios de grupo de elementos para :

Comentarios del elemento para :

Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

Newly diagnosed Malignancy AMLSG 21-13 DRKS00007189 NCT02013648 Akute myeloische Leukämie (AML)

Newly diagnosed Malignancy AMLSG 21-13 NCT02013648 Akute myeloische Leukämie (AML)

Newly diagnosed Malignancy
Descripción

Newly diagnosed Malignancy

Alias
UMLS CUI-1
C0751623
Point in time
Descripción

Point in time

Tipo de datos

integer

Alias
UMLS CUI [1,1]
C1276413
UMLS CUI [1,2]
C2348792
Maintenance Month
Descripción

Maintenance Month

Tipo de datos

integer

Alias
UMLS CUI [1,1]
C0481504
UMLS CUI [1,2]
C0439231
Date of Diagnosis
Descripción

Date of Diagnosis

Tipo de datos

date

Alias
UMLS CUI [1]
C2316983
Diagnosis
Descripción

Diagnosis

Tipo de datos

text

Alias
UMLS CUI-1
C0011900
Therapy
Descripción

Therapy

Tipo de datos

text

Alias
UMLS CUI [1]
C0087111
Comment
Descripción

Comment

Tipo de datos

text

Alias
UMLS CUI-1
C0947611
Signature
Descripción

Signature

Date
Descripción

Date

Tipo de datos

date

Alias
UMLS CUI-1
C0011008
Name of Investigator
Descripción

Name of Investigator

Tipo de datos

text

Alias
UMLS CUI-1
C0008961
Signature of investigator
Descripción

Signature of investigator

Tipo de datos

text

Alias
UMLS CUI-1
C2346576

Similar models

Newly diagnosed Malignancy AMLSG 21-13 NCT02013648 Akute myeloische Leukämie (AML)

Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
Newly diagnosed Malignancy
C0751623 (UMLS CUI-1)
Item
Point in time
integer
C1276413 (UMLS CUI [1,1])
C2348792 (UMLS CUI [1,2])
Code List
Point in time
CL Item
Diagnostic (0)
C0086143 (UMLS CUI-1)
CL Item
Induction I (1)
C3179010 (UMLS CUI-1)
CL Item
Induction II (optional) (2)
C3179010 (UMLS CUI-1)
CL Item
Consolid. I (3)
C3179017 (UMLS CUI-1)
CL Item
Consolid. II (4)
C3179017 (UMLS CUI-1)
CL Item
Consolid III (5)
C3179017 (UMLS CUI-1)
CL Item
consolid IV (6)
C3179017 (UMLS CUI-1)
CL Item
Maintenance (7)
C0481504 (UMLS CUI-1)
Item
Maintenance Month
integer
C0481504 (UMLS CUI [1,1])
C0439231 (UMLS CUI [1,2])
Code List
Maintenance Month
CL Item
after 1 Month (1)
C0439231 (UMLS CUI-1)
C0205447 (UMLS CUI-2)
CL Item
after 2 Months (2)
C0439231 (UMLS CUI-1)
C0205448 (UMLS CUI-2)
CL Item
after 3 Months (3)
C0439231 (UMLS CUI-1)
C0205449 (UMLS CUI-2)
CL Item
after 4 Months (4)
C0439231 (UMLS CUI-1)
C0205450 (UMLS CUI-2)
CL Item
after 5 Months (5)
C0439231 (UMLS CUI-1)
C0205451 (UMLS CUI-2)
CL Item
after 6 Month (6)
C0439231 (UMLS CUI-1)
C0205452 (UMLS CUI-2)
CL Item
after 7 Months (7)
C0439231 (UMLS CUI-1)
C0205453 (UMLS CUI-2)
CL Item
after 8 Months (8)
C0439231 (UMLS CUI-1)
C0205454 (UMLS CUI-2)
CL Item
after 9 Months (9)
C0439231 (UMLS CUI-1)
C0205455 (UMLS CUI-2)
CL Item
after 10 Months (10)
C0439231 (UMLS CUI-1)
C0205456 (UMLS CUI-2)
CL Item
after 11 Months (11)
C0439231 (UMLS CUI-1)
C0205457 (UMLS CUI-2)
CL Item
after 12 Months (12)
C0439231 (UMLS CUI-1)
C0205458 (UMLS CUI-2)
Date of Diagnosis
Item
Date of Diagnosis
date
C2316983 (UMLS CUI [1])
Diagnosis
Item
Diagnosis
text
C0011900 (UMLS CUI-1)
Therapy
Item
Therapy
text
C0087111 (UMLS CUI [1])
Comment
Item
Comment
text
C0947611 (UMLS CUI-1)
Item Group
Signature
Date
Item
Date
date
C0011008 (UMLS CUI-1)
Name of Investigator
Item
Name of Investigator
text
C0008961 (UMLS CUI-1)
Signature of investigator
Item
Signature of investigator
text
C2346576 (UMLS CUI-1)

Utilice este formulario para comentarios, preguntas y sugerencias.

Los campos marcados con * son obligatorios.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial